Structure/function analysis will continue on the molecular details of the interactions of proteins with components of the membrane matrix such as phospholipids and other lipid-like compounds such as steroids. Presently the core of the research centers around the high resolution crystal structure analysis of two proteins; the dimeric phospholipase A2 (PLPA2) from the venom of C. atrox which attacks phopholipids only when they are in membranes and membrane-like aggregates; and the steroid metabolizing enzyme, Delta5-3-ketosteroid isomerase (KSI). The PLPA2 from C. atrox has been solved to 2.5 A resolution by multiple isomorphous replacement augmented with real-space direct methods (MIR/DM). We intend to refine the current model and extend the resolution initially to 1.7 Angstroms and ultimately to 1.5 Angstroms. The 1.7 Angstroms refined model will serve as a basis for comparative studies with the bovine monomeric PLPA2 which prefers more loosely aggregated substrates. The sterochemistry of substrate interaction and the role of Ca2+ (and its competitors) in this process will be examined. Attempts to crystallize other PLPA2 species will be undertaken to extend and strengthen our understanding of the molecular basis of protein-membrane interactions. The KSI sturcture has been solved to 6 Angstroms resolution by MIR/DM. Significant technical difficulties imposed by a 504 Angstroms c-axis and the presence of 4 protomers in each of the 12 asymmetric units have been overcome at the 6 Angstroms level. The structure analysis of the nascent enzyme and steroid complexes will be extended to 2.5 Angstroms resolution to visualize the molecular basis fo steroid recognition in productive-mode binding. Data for the parent and one heavy-atom derivative have been recorded photographically to 2.5 Angstroms using the synchrotron light source in Orsay. Crystallization of estrogen receptor proteins will be undertaken in collaboration with Dr. Elwood Jensen's group.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM022324-09
Application #
3271096
Study Section
Biophysics and Biophysical Chemistry B Study Section (BBCB)
Project Start
1978-09-01
Project End
1985-12-31
Budget Start
1985-01-01
Budget End
1985-12-31
Support Year
9
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Han, M; Gurevich, V V; Vishnivetskiy, S A et al. (2001) Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation. Structure 9:869-80
Schubert, C; Hirsch, J A; Gurevich, V V et al. (1999) Visual arrestin activity may be regulated by self-association. J Biol Chem 274:21186-90
Hirsch, J A; Schubert, C; Gurevich, V V et al. (1999) The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation. Cell 97:257-69
Gaudet, R; Savage, J R; McLaughlin, J N et al. (1999) A molecular mechanism for the phosphorylation-dependent regulation of heterotrimeric G proteins by phosducin. Mol Cell 3:649-60
Vishnivetskiy, S A; Paz, C L; Schubert, C et al. (1999) How does arrestin respond to the phosphorylated state of rhodopsin? J Biol Chem 274:11451-4
Apanovitch, D M; Slep, K C; Sigler, P B et al. (1998) Sst2 is a GTPase-activating protein for Gpa1: purification and characterization of a cognate RGS-Galpha protein pair in yeast. Biochemistry 37:4815-22
Xu, Z; Sigler, P B (1998) GroEL/GroES: structure and function of a two-stroke folding machine. J Struct Biol 124:129-41
Bohm, A; Gaudet, R; Sigler, P B (1997) Structural aspects of heterotrimeric G-protein signaling. Curr Opin Biotechnol 8:480-7
Gaudet, R; Bohm, A; Sigler, P B (1996) Crystal structure at 2.4 angstroms resolution of the complex of transducin betagamma and its regulator, phosducin. Cell 87:577-88
Jiang, Y; Nock, S; Nesper, M et al. (1996) Structure and importance of the dimerization domain in elongation factor Ts from Thermus thermophilus. Biochemistry 35:10269-78

Showing the most recent 10 out of 29 publications